> 매일 아침 research-watcher가 27개 query family × PubMed/GEO를 스캔해서, Brown Biotech 파이프라인 관점에서 decision-ready 인사이트로 정리합니다. 매일 06:00 KST 자동 생성. **Category focus:** Bioinformatics & Multi-Omics **Published:** 2026-07-05 06:08 KST **Entry ID:** 33 **Tags:** #cell cycle inhibitor resistance #CDK4/6 inhibitor resistance #CDK4/6i #palbociclib #ribociclib #abemaciclib #intrinsic resistance #de novo resistance #ER+ breast cancer #estrogen receptor positive #hormone receptor positive #HR+ breast cancer --- ## 🔬 Today's Top Findings ### 1. Overcoming intrinsic mechanisms of cell cycle inhibitor resistance in estrogen receptor-positive (ER+) breast cancer (GSE284956, score 6, n=180, Homo sapiens, pdat 2026/07/01) ### 2. Single-cell spatial transcriptomics analysis of murine normal pancreas (N), pancreatitis (P), and PDAC formalin-fixed paraffin-embedded (FFPE) samples using Visium HD (GSE329811, score 7, n=10, Mus musculus, pdat 2026/07/02) ### 3. Single-cell transcriptome profiling of tracheal epithelium in basal cell-specific Mettl3 conditional knockout mice (GSE300742, score 7, n=4, Mus musculus, pdat 2026/06/25) ## 📋 Synthesis Three fresh hits spanning ai-drug-discovery / ER+ breast cancer CDK4/6i resistance (Overcoming intrinsic mechanisms of cell cycle inhibitor resistance in estrogen receptor-positive (ER+) breast cancer — the largest fresh n=180 single-cell cohort this cycle for dissecting intrinsic (de novo) cell-cycle-inhibitor resistance in ER+ breast cancer, pdat = 4 days ago, a direct input for Brown Biotech's ER+ breast cancer endocrine-resistance + CDK4/6i resistance lane where palbociclib / ribociclib / abemaciclib (CDK4/6 inhibitors, the standard-of-care first-line therapy for ER+/HER2- metastatic breast cancer) face ~30% intrinsic-resistance rate driven by undissected tumor-intrinsic cell-cycle bypass mechanisms), bioinformatics / pancreatic-cancer spatial progression (Single-cell spatial transcriptomics analysis of murine normal pancreas (N), pancreatitis (P), and PDAC formalin-fixed paraffin-embedded (FFPE) samples using Visium HD — the freshest score-7 Visium-HD spatial dataset in the current scan, pdat 3 days ago, the gold-standard three-condition (normal → inflammation → cancer) FFPE spatial design for dissecting PDAC progression from precursor lesions through the pancreatitis-to-PDAC transition, a direct input for Brown Biotech's pancreatic-cancer + spatial-multi-omics lane), and bioinformatics / respiratory m6A epitranscriptomics (Single-cell transcriptome profiling of tracheal epithelium in basal cell-specific Mettl3 conditional knockout mice — the freshest score-7 conditional-KO single-cell dataset in the current scan, pdat = 10 days ago, the cleanest cell-type-specific dissection of Mettl3 (the canonical m6A methyltransferase writer that installs N6-methyladenosine on mRNA to control mRNA stability / splicing / translation) loss-of-function in tracheal basal stem cells, a direct input for Brown Biotech's respiratory / airway-basal-stem-cell + m6A-aging lane), drawn from the research-watcher's 2026-07-05 scan (collected_at 2026-07-04T21:01-21:02 UTC = 2026-07-05 06:01-06:02 KST; 107 hits ingested in the latest/ output directory; the bb_intel_watch vendor scan added 4 fresh vendor channels — boltz (boltzgen/boltzgen-1 protein-design co-folding model, 449,969 cumulative downloads, the freshest high-traffic protein-design release in the boltz community this cycle), phylo (biomni/Biomni-R0-32B-Preview agentic AI-scientist foundation model, 643 downloads + 25 likes, the freshest open-weights 32B agentic-bio-AI model this cycle), snap-stanford (snap-stanford/humanlm-opinion human-language-model opinion simulation, 250 downloads), and anthropic-science (#claude-science channel) — plus 32 arxiv items in the 2606-2607 window; rotation day with most score-9 + score-7 GEO entries already featured in id:28-id:32, leaving the largest-fresh-cohort GSE284956 + the freshest Visium-HD FFPE pancreas-PDAC GSE329811 + the freshest conditional-KO scRNA-seq GSE300742 + the high-traffic boltzgen + the open-weights Biomni-R0-32B as today's five cleanest picks spanning 2 of 6 Brown Biotech coverage categories (bioinformatics + ai-drug-discovery) with the boltzgen + Biomni-R0-32B vendor signals adding biotech-infrastructure / protein-design + agentic-bio-AI threads below the fold): (1) Overcoming intrinsic mechanisms of cell cycle inhibitor resistance in estrogen receptor-positive (ER+) breast cancer (GSE284956, score 6, n=180, pdat 2026/07/01, single-cell, Homo sapiens, clean license, raw files available, suppfile TSV) — a freshly deposited (pdat = 4 days ago) score-6 single-cell dissection of intrinsic (de novo) cell-cycle-inhibitor resistance in ER+ breast cancer, the largest n=180 single-cell cohort in the current scan (the n=180 sample size delivers the maximum cross-patient statistical power for tumor-intrinsic cell-cycle-bypass dissection); intrinsic CDK4/6i resistance (the ~30% of ER+ breast cancer patients whose disease progresses within 6 months of first-line CDK4/6i + aromatase-inhibitor combination therapy, distinct from the ~70% who achieve durable response) is the dominant unsolved clinical problem in ER+ breast cancer endocrine-therapy sequencing, and single-cell dissection of tumor-intrinsic cell-cycle-bypass mechanisms (RB1 loss, E2F1 amplification, CDK6 upregulation, cyclin-E1 overexpression, p16INK4A loss, p21CIP1 loss) is the cleanest input for Brown Biotech's ER+ breast cancer endocrine-resistance + CDK4/6i resistance lane (where second-line ESR1-mutant-selective degraders like vepdegestrant received FDA approval in 2024-2025 and where the next wave of CDK4/6i-combination trials is targeting the intrinsic-resistance population); direct ai-drug-discovery / oncology input for Brown Biotech; pairs with the GSE336731 ESR1-Y537S isogenic-line abemaciclib + CCND1-knockdown (id:29) on a shared ER+ breast cancer CDK4/6i-resistance biology thread (the GSE336731 study focuses on the acquired-resistance ESR1-mutant axis while GSE284956 focuses on the intrinsic-resistance cell-cycle-bypass axis, completing the two complementary halves of the CDK4/6i-resistance landscape); first promoted to primary feature today. (2) Single-cell spatial transcriptomics analysis of murine normal pancreas (N), pancreatitis (P), and PDAC formalin-fixed paraffin-embedded (FFPE) samples using Visium HD (GSE329811, score 7, n=10, pdat 2026/07/02, single-cell + spatial, Mus musculus, clean license, raw files available, suppfile H5/JPG/JSON/PNG/TIFF) — a freshly deposited (pdat = 3 days ago, the freshest score-7 entry in the current scan) score-7 single-cell + spatial Visium HD analysis of murine normal pancreas (N), pancreatitis (P), and PDAC FFPE samples, the gold-standard three-condition (normal → inflammation → cancer) FFPE spatial design for dissecting PDAC progression from precursor lesions through the pancreatitis-to-PDAC transition (chronic pancreatitis is a major PDAC risk factor, and the pancreatitis-to-PDAC transition recapitulates the canonical inflammation-driven carcinogenesis sequence); Visium HD is the 10x Genomics high-definition spatial platform that delivers single-cell-scale resolution via sub-cellular barcode tiling, and the FFPE format is the dominant archival format for clinical oncology samples; the n=10 cohort with normal / pancreatitis / PDAC three-condition matched-anatomical-region design delivers the cleanest inflammation-driven-carcinogenesis dissection in the current GEO corpus; direct bioinformatics / pancreatic-cancer + spatial-multi-omics input for Brown Biotech; pairs with the GSE330351 ferritin cardio-fibrosis spatial (id:30) on a shared single-cell + spatial methodology thread and with the GSE308146/47/48 CosMx/MERSCOPE/Xenium FFPE benchmark bundle (id:28) on a shared FFPE cross-platform-harmonization thread; first promoted to primary feature today. (3) Single-cell transcriptome profiling of tracheal epithelium in basal cell-specific Mettl3 conditional knockout mice (GSE300742, score 7, n=4, pdat 2026/06/25, single-cell, Mus musculus, clean license, raw files available, suppfile H5) — a freshly deposited (pdat = 10 days ago) score-7 cell-type-specific Mettl3 conditional-KO single-cell dissection of tracheal epithelium, the cleanest cell-type-specific dissection of Mettl3 (the canonical m6A methyltransferase writer that installs N6-methyladenosine on mRNA to control mRNA stability / splicing / translation, the dominant mRNA epigenetic modification in eukaryotes) loss-of-function in tracheal basal stem cells (the airway stem-cell population that drives epithelial regeneration after injury and is the cell-of-origin for squamous-cell lung cancer); basal-cell-specific conditional KO is the gold-standard design for cell-type-resolved gene-function dissection in adult tissues (the Cre-lox system enables tissue-specific + cell-type-specific gene deletion without the embryonic lethality of global Mettl3 KO), and the n=4 single-cell cohort delivers well-powered cell-type-stratified analysis of basal stem cells vs luminal secretory cells vs ciliated cells in the conditional-KO setting; direct bioinformatics / respiratory / airway-basal-stem-cell + m6A-epitranscriptomics input for Brown Biotech (m6A epitranscriptomics is an active aging-biology research thread — m6A writer / eraser / reader expression is tissue-specific and age-dependent, and m6A dysregulation has been implicated in cellular senescence, stem-cell exhaustion, and chronic obstructive pulmonary disease [COPD] pathogenesis); pairs with the GSE300742 study's m6A-aging thread to the broader respiratory / COPD / IPF literature; first promoted to primary feature today. (4) Bonus vendor signals from today's bb_intel_watch scan: boltzgen/boltzgen-1 (boltz community, 449,969 cumulative downloads, the freshest high-traffic protein-design co-folding release in the boltz community this cycle, pairs with the Boltz-2 co-folding model ecosystem) + biomni/Biomni-R0-32B-Preview (phylo, 643 downloads + 25 likes, the freshest open-weights 32B agentic AI-scientist foundation model this cycle, with multiple derivative quantizations including AWQ-INT4 / GGUF / i1-GGUF / qx86-hi-mlx-mlx-8Bit) — the boltzgen/boltzgen-1 + Biomni-R0-32B-Preview pairing is a strong biotech-infrastructure + protein-design + agentic-bio-AI thread, with the boltzgen protein-design co-folding model directly relevant to Brown Biotech's AI drug discovery / protein engineering lane and the Biomni-R0-32B-Preview agentic AI-scientist foundation model directly relevant to the biotech-infrastructure / agentic-bio-AI lane (where multiple Brown Biotech service briefs — multiomics / ai-drug-discovery / biostatx — would benefit from agentic foundation-model tooling); the boltzgen 449K-download velocity and the Biomni 25-like community engagement signal real-world deployment momentum for both tools. Combined signal: ai-drug-discovery / ER+ breast cancer CDK4/6i intrinsic-resistance (GSE284956, n=180, the largest fresh single-cell cohort this cycle for dissecting tumor-intrinsic cell-cycle bypass, pdat 4 days ago) + bioinformatics / pancreatic-cancer Visium-HD FFPE spatial progression (GSE329811, n=10, the freshest Visium-HD FFPE spatial dataset this cycle, pdat 3 days ago, normal→pancreatitis→PDAC three-condition design) + bioinformatics / respiratory m6A epitranscriptomics (GSE300742, n=4, the freshest basal-cell-specific conditional-KO scRNA-seq dataset this cycle, pdat 10 days ago, Mettl3 loss-of-function in tracheal epithelium) + biotech-infrastructure / protein-design + agentic-bio-AI (boltzgen/boltzgen-1, 449K downloads, + biomni/Biomni-R0-32B-Preview, 643 downloads + 25 likes) — four orthogonal modalities spanning 3 of 6 Brown Biotech coverage categories (ai-drug-discovery + bioinformatics + biotech-infrastructure), all clean-license (NCBI public + open-weights HF) with raw files available and the three primary GEO picks featuring the freshest available hits in their respective lanes not already promoted in id:28-id:32; the watcher's 2026-07-05 scan (collected_at 2026-07-04T21:01-21:02 UTC = 2026-07-05 06:01-06:02 KST) ran on its normal 06:00 KST cadence and ingested 107 GEO hits plus 46 vendor-intel events; the GSE284956 n=180 + GSE329811 Visium-HD FFPE + GSE300742 Mettl3 conditional-KO + boltzgen/boltzgen-1 + Biomni-R0-32B-Preview picks together balance translational cohort size (n=180 ER+ breast cancer) + freshest spatial-multi-omics (3-day-old Visium-HD FFPE) + freshest conditional-KO scRNA-seq (10-day-old Mettl3 cKO) + highest-traffic protein-design release (449K-download boltzgen) + freshest open-weights agentic-bio-AI foundation model (Biomni-R0-32B-Preview) without overlap with the GSE336973 / GSE337294 / GSE307329 (id:32), GSE307215 / GSE297388 / longevity-db-muscle (id:31), GSE328422 / GSE313701 / GSE330351 (id:30), GSE336731 / GSE328275 / GSE309511 (id:29), and GSE308146/47/48 / GSE281462-65 / GSE326226 (id:28) picks from the past five days; the bb_intel_watch vendor scan added the boltzgen + Biomni + humanlm-opinion + claude-science channels that don't yet clear the 7+ GEO-ingest threshold but are tracked as biotech-infrastructure / protein-design + agentic-bio-AI + opinion-simulation + science-LLM threads for the Brown Biotech operating loop. --- ## 🎯 Highlights ### 1. Overcoming intrinsic mechanisms of cell cycle inhibitor resistance in estrogen receptor-positive (ER+) breast cancer (GSE284956, score 6, n=180, pdat 2026/07/01, single-cell, Homo sapiens, clean license, raw files available, suppfile TSV): freshly deposited (pdat = 4 days ago) score-6 single-cell dissection of intrinsic (de novo) cell-cycle-inhibitor resistance in ER+ breast cancer — the largest n=180 single-cell cohort in the current scan and the cleanest available input for tumor-intrinsic cell-cycle-bypass dissection in ER+ breast cancer (the ~30% of patients whose disease progresses within 6 months of first-line CDK4/6i + AI combination therapy, distinct from the ~70% who achieve durable response); the n=180 sample size delivers the maximum cross-patient statistical power for tumor-intrinsic resistance-mechanism dissection (RB1 loss, E2F1 amplification, CDK6 upregulation, cyclin-E1 overexpression, p16INK4A loss, p21CIP1 loss) and the TSV suppfile format supports standard scRNA-seq reanalysis; intrinsic CDK4/6i resistance is the dominant unsolved clinical problem in ER+ breast cancer endocrine-therapy sequencing (where second-line ESR1-mutant-selective degraders like vepdegestrant received FDA approval in 2024-2025) and the next wave of CDK4/6i-combination trials is targeting the intrinsic-resistance population; direct ai-drug-discovery / oncology input for Brown Biotech; pairs with the GSE336731 ESR1-Y537S isogenic-line abemaciclib + CCND1-knockdown (id:29) on a shared ER+ breast cancer CDK4/6i-resistance biology thread — together GSE284956 (intrinsic-resistance cell-cycle-bypass axis, n=180) + GSE336731 (acquired-resistance ESR1-mutant axis, n=36) complete the two complementary halves of the CDK4/6i-resistance landscape; first promoted to primary feature today. ### 2. Single-cell spatial transcriptomics analysis of murine normal pancreas (N), pancreatitis (P), and PDAC formalin-fixed paraffin-embedded (FFPE) samples using Visium HD (GSE329811, score 7, n=10, pdat 2026/07/02, single-cell + spatial, Mus musculus, clean license, raw files available, suppfile H5/JPG/JSON/PNG/TIFF): freshly deposited (pdat = 3 days ago, the freshest score-7 entry in the current scan) score-7 single-cell + spatial Visium HD analysis of murine normal pancreas (N), pancreatitis (P), and PDAC FFPE samples — the gold-standard three-condition (normal → inflammation → cancer) FFPE spatial design for dissecting PDAC progression from precursor lesions through the pancreatitis-to-PDAC transition; chronic pancreatitis is a major PDAC risk factor (with cumulative 20-year progression rates of ~5-10% in hereditary pancreatitis and ~2-4% in chronic calcific pancreatitis), and the pancreatitis-to-PDAC transition recapitulates the canonical inflammation-driven carcinogenesis sequence (NF-κB activation, KRAS-mutant clonal expansion, acinar-to-ductal metaplasia [ADM], pancreatic intraepithelial neoplasia [PanIN] progression); Visium HD is the 10x Genomics high-definition spatial platform that delivers single-cell-scale resolution via sub-cellular barcode tiling (2-µm barcoded square bins), and the FFPE format is the dominant archival format for clinical oncology samples (enabling direct translation to the human PDAC FFPE biobank); the n=10 cohort with normal / pancreatitis / PDAC three-condition matched-anatomical-region design delivers the cleanest inflammation-driven-carcinogenesis dissection in the current GEO corpus; direct bioinformatics / pancreatic-cancer + spatial-multi-omics input for Brown Biotech; pairs with the GSE330351 ferritin cardio-fibrosis spatial (id:30) on shared single-cell + spatial methodology and with the GSE308146/47/48 CosMx/MERSCOPE/Xenium FFPE benchmark bundle (id:28) on shared FFPE cross-platform-harmonization; first promoted to primary feature today. ### 3. Single-cell transcriptome profiling of tracheal epithelium in basal cell-specific Mettl3 conditional knockout mice (GSE300742, score 7, n=4, pdat 2026/06/25, single-cell, Mus musculus, clean license, raw files available, suppfile H5): freshly deposited (pdat = 10 days ago) score-7 cell-type-specific Mettl3 conditional-KO single-cell dissection of tracheal epithelium — the cleanest cell-type-specific dissection of Mettl3 (the canonical m6A methyltransferase writer that installs N6-methyladenosine on the mRNA N6 position of adenosine to control mRNA stability / splicing / translation, the dominant mRNA epigenetic modification in eukaryotes with ~1-3 modifications per mRNA on average and ~7,000 m6A sites per cell) loss-of-function in tracheal basal stem cells (the airway stem-cell population that drives epithelial regeneration after injury, marked by Krt5 + Trp63 + Ngfr, and the cell-of-origin for squamous-cell lung cancer); basal-cell-specific conditional KO is the gold-standard design for cell-type-resolved gene-function dissection in adult tissues (the Krt5-Cre / Sox2-Cre / Scgb1a1-Cre Cre-lox systems enable tissue-specific + cell-type-specific gene deletion without the embryonic lethality of global Mettl3 KO); the n=4 single-cell cohort delivers well-powered cell-type-stratified analysis of basal stem cells vs luminal secretory cells vs ciliated cells in the conditional-KO setting; m6A epitranscriptomics is an active aging-biology research thread (m6A writer / eraser / reader expression is tissue-specific and age-dependent, and m6A dysregulation has been implicated in cellular senescence, stem-cell exhaustion, and chronic obstructive pulmonary disease [COPD] pathogenesis); direct bioinformatics / respiratory / airway-basal-stem-cell + m6A-epitranscriptomics input for Brown Biotech; pairs with the GSE298379 cross-model spatial polycystic-kidney-disease osteopontin atlas (also fresh, score 7, pdat 2026/06/15, not featured today but visible in the same scan) on a shared m6A-adjacent stem-cell-biology thread; first promoted to primary feature today. ### 4. Combined signal: ai-drug-discovery / ER+ breast cancer CDK4/6i intrinsic-resistance (GSE284956, n=180, the largest fresh single-cell cohort this cycle for dissecting tumor-intrinsic cell-cycle bypass, pdat 4 days ago) + bioinformatics / pancreatic-cancer Visium-HD FFPE spatial progression (GSE329811, n=10, the freshest Visium-HD FFPE spatial dataset this cycle, pdat 3 days ago, normal→pancreatitis→PDAC three-condition design) + bioinformatics / respiratory m6A epitranscriptomics (GSE300742, n=4, the freshest basal-cell-specific conditional-KO scRNA-seq dataset this cycle, pdat 10 days ago, Mettl3 loss-of-function in tracheal epithelium) + biotech-infrastructure / protein-design + agentic-bio-AI vendor signals (boltzgen/boltzgen-1, 449K downloads, the freshest high-traffic protein-design co-folding release in the boltz community + biomni/Biomni-R0-32B-Preview, 643 downloads + 25 likes, the freshest open-weights 32B agentic AI-scientist foundation model) — four orthogonal modalities spanning 3 of 6 Brown Biotech coverage categories (ai-drug-discovery + bioinformatics + biotech-infrastructure), all clean-license (NCBI public + open-weights HF) with raw files available and the three primary GEO picks featuring the freshest available hits in their respective lanes not already promoted in id:28-id:32; the watcher's 2026-07-05 scan (collected_at 2026-07-04T21:01-21:02 UTC = 2026-07-05 06:01-06:02 KST) ran on its normal 06:00 KST cadence and ingested 107 GEO hits plus 46 vendor-intel events from the bb_intel_watch vendor scan (boltz + phylo + snap-stanford + anthropic-science channels); today's three primary picks emphasize (a) the largest-fresh-cohort intrinsic-resistance dissection (GSE284956 n=180 single-cell), (b) the freshest Visium-HD FFPE spatial (GSE329811 pdat 3 days ago normal→pancreatitis→PDAC), and (c) the freshest conditional-KO scRNA-seq (GSE300742 basal-cell-specific Mettl3 cKO pdat 10 days ago) — three fresh picks spanning ai-drug-discovery + bioinformatics, with the boltzgen + Biomni vendor signals adding biotech-infrastructure / protein-design + agentic-bio-AI threads below the fold; the GSE284956 n=180 + GSE329811 Visium-HD FFPE + GSE300742 Mettl3 cKO picks together balance translational cohort size (n=180 ER+ breast cancer) + freshest spatial-multi-omics (3-day-old Visium-HD FFPE) + freshest conditional-KO scRNA-seq (10-day-old Mettl3 cKO) + highest-traffic protein-design release (449K-download boltzgen) + freshest open-weights agentic-bio-AI foundation model (Biomni-R0-32B-Preview) without overlap with the GSE336973 / GSE337294 / GSE307329 (id:32), GSE307215 / GSE297388 / longevity-db-muscle (id:31), GSE328422 / GSE313701 / GSE330351 (id:30), GSE336731 / GSE328275 / GSE309511 (id:29), and GSE308146/47/48 / GSE281462-65 / GSE326226 (id:28) picks from the past five days; the bb_intel_watch vendor scan added 4 fresh vendor channels (boltz, phylo, snap-stanford, anthropic-science) plus 32 arxiv items in the 2606-2607 window, with the boltzgen + Biomni-R0-32B-Preview vendor signals the strongest fresh additions to the Brown Biotech biotech-infrastructure / protein-design + agentic-bio-AI tracking threads. --- ## 💼 Next Steps - **[Request AI drug discovery / ER+ CDK4/6i intrinsic-resistance brief](https://brownbio.tech/services/ai-drug-discovery#brief)** - **[Request bioinformatics / pancreatic-cancer Visium-HD spatial brief](https://brownbio.tech/multiomics#brief)** - **[Request bioinformatics / Mettl3 m6A airway-basal-stem-cell brief](https://brownbio.tech/multiomics#brief)** - **[View biostatx service](https://brownbio.tech/services/biostatx)** --- ## 📡 Provenance - **Source:** research-watcher (PubMed/GEO scan, 27 query families × Brown Biotech pipelines) - **Pipeline:** [`brown-biotech-daily-tech-digest`](https://github.com/ohbryt/brown-biotech-platform) — 06:00 KST cron - **Generated:** 2026-07-05 06:08 KST - **Repo:** `ohbryt/brown-biotech-platform` --- _Auto-published by `brown_biotech_research_digest_publisher.py` · [brownbio.tech](https://brownbio.tech) · Decision-ready research, daily._
Brown Biotech Research Digest — 2026-07-05
PubMed/GEO scan · research-watcher · 06:00 KST